ResQ Biotech
Greece - PatraBiotechnology
Focus: ResQ Biotech is a publicly traded biotechnology company founded in 2002, headquartered in Patras, Greece, focused on developing therapies for protein misfolding diseases with current emphasis in ophthalmology.
Profile data last refreshed 5h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
3+2 this month
Stable — net +2 jobs in 30d
5 added, 3 removed. Backfill posture.
Should You Work at ResQ Biotech?
AI assessmentResQ Biotech is a speculative opportunity for scientists committed to protein misfolding biology in a stable but data-sparse public biotech; due diligence on pipeline stage and cash position is essential before committing.
Why Work Here
- Established 20+ year track record in specialized protein misfolding disease area with focused therapeutic strategy
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for ResQ Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.